SPOTLIGHT -
Although the clinical symptoms of psychotic disorders are dramatic and are what most clinicians focus on as their treatment targets, impairments in a wide range of cognitive function are observed in these illnesses.
Ingrezza Sprinkle Capsules Received FDA Approval for Tardive Dyskinesia in Adults
Treating ‘Morally Objectionable’ Patients
Psychiatry in the News: April 2024
What Will the Future of Alzheimer Disease Treatment Look Like?
Clozapine: Once-Daily or Divided Dosing?
Management of Borderline Personality Disorder in an Obstetric Unit